Generation of reactive intermediates from the tumor promoter butylated hydroxytoluene hydroperoxide in isolated murine keratinocytes or by hematin
- 1 July 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 10 (7) , 1261-1268
- https://doi.org/10.1093/carcin/10.7.1261
Abstract
BHTOOH (2, 6-di-tert-butyl-4-hydroperoxyl-4-methyl-2, 5-cyclohexadienone), a metabolite of the food antioxidant BHT (2, 6-di-tert-butyl-4-methylphenol), has previously been shown to function as a tumor promoter in mouse skin. The metabolism of BHTOOH was examined to assess the role of reactive intermediates in mediating tumor promotion in this tissue. Free radical metabolites of BHTOOH were characterized in either isolated neonatal mouse keratinocytes or a cell-free hematin system using electron paramagnetic resonance (EPR) spectroscopy while non-radical, EPR silent products were characterized using HPLC separation coupled with UV or mass spectral detection. Incubation of BHTOOH with keratinocytes or hematin resulted in the generation of the BHT-phenoxyl radical detectable by EPR spectroscopy. Formation of the BHT-phenoxyl radical was prevented by heat inactivation of the cells prior to exposure to BHTOOH. Only one non-radical metabolite of BHTOOH was detected in keratinocytes: BHT-quinol (2, 6-di-tert-butyl-4-methyl-4-hydroxyl-2,5-cyclohexadianone), while incubation of BHTOOH with hematin produced several metabolites: oxacyclopen-tenone (2, 5-di-tert-butyl-5-(2'-oxopropyl)-4-oxa-2-cyclopen-tenone), BHT-quinone (2, 6-di-tert-butyl-p-benzoquinone), BHT, BHT-stilbenequinone (3, 5,3',5'-tetra-tert-butylstilbene-4, 4'-quinone), and BHT-quinone methide (2, 6-di-tert-butyl-4-methylene-2, 5-cyclohexadienone). Thus, radical as well as non-radical reactive intermediates can be formed during metabolism of BHTOOH. Several of the stable metabolites of BHTOOH were evaluated for possible promoter activity in a short-term bioassay, induction of ornithine decarboxylase (ODC) activity in mouse skin. In contrast to the action of BHTOOH, topical application of equimolar doses of BHT-quinol, BHT-quinone, BHT-stilbenequinone, as well as BHT itself, did not induce epidermal ODC activity. Thus, reactive metabolites of BHTOOH such as the BHT-phenoxyl radical or BHT-quinone methide may be involved in the molecular mechanisms of action of this hydroperoxide tumor promoter.Keywords
This publication has 23 references indexed in Scilit:
- Pulmonary toxicity of butylated hydroxytoluene and related alkylphenols: Structural requirements for toxic potency in mice*1Toxicology and Applied Pharmacology, 1982
- Biotransformation of butylated hydroxytoluene (BHT) to BHT-quinone methide in rats.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981
- The acute toxicity of butylated hydroxytoluene and its metabolites in miceToxicology Letters, 1980
- 2,6-di-tert-butyl-4- methylene-2,5-cyclohexadienone: A hepatic metabolite of butylated hydroxytoluene in ratsFood and Cosmetics Toxicology, 1979
- Enhancement of adenoma formation in mouse lung by butylated hydroxytolueneToxicology and Applied Pharmacology, 1979
- Biological fate of butylated hydroxytoluene (BHT); Binding in vivo of BHT to macromolecules of rat liver.CHEMICAL & PHARMACEUTICAL BULLETIN, 1979
- Identification of new metabolites of butylated hydroxytoluene (BHT) in rats.Journal of Pharmacobio-Dynamics, 1979
- Dose-response study of hemorrhagic death by dietary butylated hydroxytoluene (BHT) in male ratsToxicology and Applied Pharmacology, 1978
- LACK OF TUMOR-PROMOTING ABILITY OF CERTAIN ENVIRONMENTAL CHEMICALS IN A 2-STAGE MOUSE SKIN TUMORIGENESIS ASSAY1978
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976